Since this drug is used in clinical trials for patients with graft versus host disease (GVHD) and psoriasis (Yiu and Warren, 2016; MacDonald et al., 2017) (Table 1), ROCK2 inhibitors may could be used to treat DKD. The gene discussed is ROCK2; the disease is graft versus host disease.